IJ
INSIDER · TVTX · Travere Therapeutics, Inc. · EVP, HEAD OF R&D & CMO
Inrig Jula
Every open-market transaction filed under this name, Sep 15 to Sep 15.
Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$2.8M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 15 | TVTX | Travere Therapeutics, Inc. | EVP, Head of R&D & CMO | Sell | 400 | $65.31 | $26K | −19.7% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | EVP, Head of R&D & CMO | Sell | 1,600 | $63.69 | $102K | −17.7% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | EVP, Head of R&D & CMO | Sell | 17,284 | $62.62 | $1.1M | −16.3% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | EVP, Head of R&D & CMO | Sell | 25,390 | $62.02 | $1.6M | −15.5% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.